Shield Therapeutics (LSE:STX) 3-Year Book Growth Rate : -57.10% (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics 3-Year Book Growth Rate?

Shield Therapeutics's Book Value per Share for the quarter that ended in Jun. 2023 was £0.04.

During the past 12 months, Shield Therapeutics's average Book Value per Share Growth Rate was -74.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -57.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -36.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 9 years, the highest 3-Year average Book Value per Share Growth Rate of Shield Therapeutics was -10.10% per year. The lowest was -57.10% per year. And the median was -16.75% per year.

Competitive Comparison of Shield Therapeutics's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shield Therapeutics's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's 3-Year Book Growth Rate falls into.

Shield Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Shield Therapeutics (LSE:STX) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Shield Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (LSE:STX) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

SHIEF:USA 1JS:Germany

Address

Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF

Website

https://www.shieldtherapeutics.com

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.